Cause of Death
Evel Knievel died from pulmonary fibrosis, a progressive and currently incurable lung disease that causes scarring of the lung tissue and chronic shortness of breath. He was diagnosed in the years leading up to his death and managed the condition with oxygen therapy and reduced activity. He died on November 30, 2007, at age 69. The official cause on his death certificate is respiratory failure due to pulmonary fibrosis, reflecting a decline that lasted several months.
Medical Details and Diagnosis Path
Pulmonary Fibrosis Explained
Pulmonary fibrosis (PF) belongs to a larger group of illnesses called interstitial lung diseases. In PF, the lungs become stiff because scar tissue replaces normal, healthy tissue. This scarring makes it harder for the lungs to move oxygen into the bloodstream, leading to breathlessness with everyday tasks. The condition is more common in older adults and tends to develop and worsen over months to years rather than days. There is no cure, but treatments can sometimes slow progression and relieve symptoms.
How Pulmonary Fibrosis Affected Knievel
Knievel’s lung condition was consistent with idiopathic pulmonary fibrosis (IPF) or a related form of interstitial lung disease. Over time, this would have reduced his exercise tolerance and required increasing reliance on supplemental oxygen. By his final years, simple activities such as climbing stairs or short walks could provoke severe breathlessness. His medical management likely included oxygen therapy and medications to ease symptoms, though disease-modifying drugs for IPF were not available during the later part of his life.
Timeline of Final Years and Death
In the early 2000s, Knievel acknowledged health issues publicly and curtailed physical activity. By 2006, reports noted his use of oxygen and a more frail appearance. He lived long enough to see renewed public interest in stunt history and to grant interviews reflecting on risk, family, and legacy. He passed away in 2007 at his home in Grass Valley, California, under hospice care. His death was widely reported at the time, and the stated medical cause was respiratory failure secondary to pulmonary fibrosis.
Complications and Prognosis Insights
Pulmonary fibrosis often leads to complications such as pulmonary hypertension, heart strain, and increased susceptibility to respiratory infections. These complications can accelerate decline and contribute to the terminal phase, as was the case with Knievel. The prognosis for advanced PF is generally guarded, with median survival varying by subtype but typically measured in years rather than decades once the disease is advanced. Knievel’s case illustrates how chronic lung disease can gradually impact even the most physically daring individuals.
Evel Knievel at a Glance
A compact overview of notable biographical and medical attributes relevant to understanding Knievel’s life and cause of death.
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Full Name | Robert Craig Knievel | Official biographies |
| Date of Birth | October 17, 1938 | Public records |
| Date of Death | November 30, 2007 | Obituaries |
| Age at Death | 69 years | Obituaries |
| Official Cause of Death | Respiratory failure due to pulmonary fibrosis | Death certificate and reputable obituaries |
| Known Health Issues in Later Life | Pulmonary fibrosis, oxygen use, reduced mobility | Interviews and medical reports |
| Place of Death | Grass Valley, California, USA | News reports |
Legacy and Public Memory
Knievel’s legacy endures in stunt performance, popular mythology, and risk culture. He is remembered for large-scale jump attempts, charismatic showmanship, and building a personal brand around danger and determination. His health struggles in later years brought more attention to the physical toll of stunt performance and the long-term risks associated with repeated trauma. Modern references to Knievel often emphasize both his spectacular successes and the human cost of a career defined by extreme risk-taking.
Comparisons to Modern Stunt Performers
Today’s stunt professionals benefit from advanced safety equipment, better medical monitoring, and stricter risk assessment practices. Whereas Knievel often relied on minimal protective gear and sheer will, contemporary performers use engineered systems, on-site medical teams, and detailed contingency plans. This shift reflects broader cultural changes in how society views acceptable risk, informed in part by high-profile injuries and deaths of earlier icons like Knievel.
Conclusion and Verified Summary
Evel Knievel died from pulmonary fibrosis, a chronic and progressive lung disease that led to respiratory failure in 2007. Verified sources agree on this cause and on the timeline of his final months, during which he required oxygen and experienced significant decline. His story remains a powerful example of how occupational risk-taking can exact a physical toll over time. Understanding his cause of death in medical context helps clarify myths and underscores the lasting impact of his career on public perceptions of stunt performance and safety.